AiTA Bio, a New York-based bio-MEMS company, today announced it has secured $8.5 million in Series A funding led by Hammerstone Capital, BlackPoint Partners,...
Shanghai Zhimeng Biopharma, Inc. ("Zhimeng"), announced dosing of the first participant in the US Phase I study in healthy subjects of its innovative small-molecule...
Strata Oncology, Inc., a next-generation precision oncology company enabling smarter and earlier cancer treatment, announced enrollment of the first patient in the Strata Precision...
Memora Health, the leading technology platform for virtual care delivery and complex care management, announced a partnership with Reimagine Care, an innovative provider of...
Diagnostics are the foundation of disease detection, diagnosis, and assessment. Diagnostics inform more than 70% of medical decisions about disease treatment, management, and prevention....
